**Qiming Venture Partners Reduces Fund Target Amid Investor Caution**
Qiming Venture Partners has announced a significant reduction in its new fund aimed at Chinese AI and healthcare startups, lowering its target from $800 million to $600 million. This decision reflects ongoing caution among global investors regarding the Chinese technology sector. The firm, known for its early investments in companies like Meituan and Xiaomi Corp., adjusted its target after potential investors expressed a preference for smaller investment pools.
Led by founding managing partner Duane Kuang, Qiming is part of a growing number of US-dollar funds based in China that are actively seeking capital. The market has seen a resurgence this year, driven by a new wave of startups, including DeepSeek and Unitree Robotics. Initially, Qiming aimed to raise up to $1 billion for its new fund, but it has since opted for a more conservative approach.
Other firms in the sector, such as Lightspeed China Partners and Source Code Capital, are also focusing on smaller funds, ranging from $150 million to $400 million. Qiming has not provided comments on its fundraising strategy.
US investors looking to invest in Chinese technology face significant challenges, including economic instability and regulatory uncertainties. Many endowments and pension funds that previously supported China’s internet growth have become more cautious, with some withdrawing their investments entirely. Concerns include a bleak economic outlook for China, rising tensions between the US and China, and restrictions on AI-related investments imposed by the US government.
Qiming’s fundraising efforts are still evolving and may change as market conditions fluctuate. In 2022, the firm successfully closed its previous US-dollar fund at $2.5 billion, targeting both early and growth-stage technology and healthcare startups. This was followed by a $700 million fund from 5Y Capital, which was oversubscribed and closed at $795 million early last year, despite the tumultuous economic landscape as China emerged from COVID-19 lockdowns. However, the pace of deal flow has noticeably slowed since then.
**FAQ**
**What factors are influencing Qiming Venture Partners’ decision to reduce its fund target?**
Qiming Venture Partners’ decision to lower its fund target is influenced by investor caution regarding the Chinese tech sector, economic uncertainties, and regulatory challenges, particularly from the US government.
